{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:53:47Z","timestamp":1782406427679,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"crossref","award":["#01T-106"],"award-info":[{"award-number":["#01T-106"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","plefa.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.plefa.2017.10.002","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T04:15:54Z","timestamp":1508127354000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Neurocognitive effects of an omega-3 fatty acid and vitamins E+C in schizophrenia: A randomised controlled trial"],"prefix":"10.1016","volume":"136","author":[{"given":"H.","family":"Bentsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.I.","family":"Landr\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2017.10.002_bib1","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1038\/tp.2013.110","article-title":"A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia","volume":"3","author":"Bentsen","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopsych.2011.02.011","article-title":"Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder","volume":"70","author":"Bentsen","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib3","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.4088\/JCP.1006e12","article-title":"Cognitive impairment and functional outcome in schizophrenia and bipolar disorder","volume":"67","author":"Green","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib4","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"19","author":"Mueser","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2017.10.002_bib5","first-page":"623","article-title":"The Hopkins verbal learning test and CVLT: a preliminary comparison","volume":"13","author":"Lacritz","year":"1998","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.plefa.2017.10.002_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1997.01830140071013","article-title":"Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia","volume":"54","author":"Gold","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib7","series-title":"A Compendium of Neuropsychological Tests: Administration, Norms and Commentary","author":"Spreen","year":"1998"},{"key":"10.1016\/j.plefa.2017.10.002_bib8","unstructured":"M.D. Lezak, D.B. Howieson, D.W. Loring, Orientation and attention, in: Neuropsychological Assessment, 4th ed, Oxford University Press, New York, 2004, pp. 337\u2013368."},{"key":"10.1016\/j.plefa.2017.10.002_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-1781(89)90188-1","article-title":"The continuous performance test identical pairs version: II. Contrasting attentional profiles in schizophrenia and depressed patients","volume":"29","author":"Cornblatt","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpsychires.2006.06.010","article-title":"Re-examining sustained attention deficits as vulnerability indicators for schizophrenia: stability in the long term course","volume":"40","author":"Liu","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.schres.2011.08.025","article-title":"Impaired cognitive inhibition in schizophrenia: a meta-analysis of the Stroop interference effect","volume":"133","author":"Westerhausen","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib12","unstructured":"M.D. Lezak, D.B. Howiesen, E.D. Bigler, D. Tranel, Executive functions, in: Neuropsychological Assessment, 5th ed, Oxford University Press, New York, 2012, pp. 666\u2013711."},{"key":"10.1016\/j.plefa.2017.10.002_bib13","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.plefa.2017.10.002_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10543400802609797","article-title":"MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets","volume":"19","author":"Siddiqui","year":"2009","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.plefa.2017.10.002_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing \u2013 when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.plefa.2017.10.002_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","article-title":"Multiplicity in randomised trials I: endpoint and treatments","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2017.10.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.04.002","article-title":"The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data","volume":"359","author":"Henderson","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.plefa.2017.10.002_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/bmj.289.6441.336","article-title":"A fair trial?","volume":"289","author":"Altman","year":"1984","journal-title":"Br. Med. J."},{"key":"10.1016\/j.plefa.2017.10.002_bib19","series-title":"Benefit-risk Assessment of Fish and Fish Products in the Norwegian Diet \u2013 an update","volume":"15","author":"VKM","year":"2014"},{"key":"10.1016\/j.plefa.2017.10.002_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/87.2.362","article-title":"Vitamin status in morbidly obese patients: a cross-sectional study","volume":"87","author":"Aasheim","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2017.10.002_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.pnpbp.2011.04.009","article-title":"Working memory and attention deficits in adolescent offspring of schizophrenia or bipolar patients: comparing vulnerability markers","volume":"35","author":"Diwadkar","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.schres.2006.08.030","article-title":"Reaction time of the continuous performance test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls","volume":"89","author":"Wang","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1017\/S095457940606041X","article-title":"Translating basic attentional paradigms to schizophrenia research: reconsidering the nature of the deficits","volume":"18","author":"Nuechterlein","year":"2006","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.plefa.2017.10.002_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jsfa.7320","article-title":"Phospholipids in foods: prooxidants or antioxidants?","volume":"96","author":"Cui","year":"2016","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.plefa.2017.10.002_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/mnfr.200900439","article-title":"The location and behavior of a-tocopherol in membranes","volume":"54","author":"Atkinson","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib26","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bpj.2015.08.032","article-title":"\u03b1-tocopherol is well designed to protect polyunsaturated phospholipids: MD simulations","volume":"109","author":"Leng","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.plefa.2017.10.002_bib27","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1007\/s12035-015-9392-y","article-title":"The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling: new drug targets in neuroimmune disorders","volume":"53","author":"Morris","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.plefa.2017.10.002_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.04.009","article-title":"Plasma total antioxidant status and cognitive impairments in schizophrenia","volume":"139","author":"Zhang","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1179\/1476830515Y.0000000032","article-title":"Association of blood antioxidants status with visual and auditory sustained attention","volume":"18","author":"Shiraseb","year":"2015","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.plefa.2017.10.002_bib30","first-page":"289","article-title":"A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: possible stage-specific effects","volume":"27","author":"Chen","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008919.pub2","article-title":"Antioxidant treatments for schizophrenia","author":"Magalh\u00e3es","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.plefa.2017.10.002_bib32","first-page":"210","article-title":"N-3 polyunsaturated fatty acids, lipid microclusters, and vitamin E","volume":"75","author":"Shaikh","year":"2015","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.plefa.2017.10.002_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0007114513002444","article-title":"Dietary fish oil and DHA down-regulate antigen-activated CD41+ T-cells while promoting the formation of liquid-ordered mesodomains","volume":"111","author":"Kim","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.plefa.2017.10.002_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2012.03.008","article-title":"Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids","volume":"88","author":"Turk","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plefa.2017.10.002_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.plefa.2013.09.011","article-title":"Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes","volume":"89","author":"Fenton","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plefa.2017.10.002_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bpj.2012.06.016","article-title":"Docosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains","volume":"103","author":"Williams","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.plefa.2017.10.002_bib37","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1038\/tp.2016.142","article-title":"Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations","volume":"6","author":"Tessier","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00213-008-1129-4","article-title":"Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis","volume":"199","author":"Heekeren","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.plefa.2017.10.002_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euroneuro.2014.01.007","article-title":"OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study","volume":"24","author":"Bron","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2017.10.002_bib40","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamin-induced deficits in auditory and visual context-dependent processing in healthy volunteers. Implications for models of cognitive deficits in schizophrenia","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2017.10.002_bib41","doi-asserted-by":"crossref","first-page":"188e195","DOI":"10.1016\/j.jpsychires.2014.12.007","article-title":"Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings","volume":"61","author":"Levin","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib42","first-page":"267","article-title":"Paying attention to MMN in schizophrenia","volume":"2015","author":"Damaso","year":"1626","journal-title":"Brain Res."},{"key":"10.1016\/j.plefa.2017.10.002_bib43","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.npp.1301624","article-title":"Glutathione precursor, n-acetyl-cysteine, improves mismatch negativity in schizophrenia patients","volume":"33","author":"Lavoie","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.plefa.2017.10.002_bib44","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.plefa.2017.10.002_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2013.00031","article-title":"NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia","volume":"7","author":"Snyder","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.plefa.2017.10.002_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coph.2014.12.004","article-title":"The NMDA receptor \u2018glycine modulatory site\u2019 in schizophrenia: D-serine, glycine, and beyond","volume":"20","author":"Balu","year":"2015","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232781730011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232781730011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:49:26Z","timestamp":1539996566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232781730011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":46,"alternative-id":["S095232781730011X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2017.10.002","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurocognitive effects of an omega-3 fatty acid and vitamins E+C in schizophrenia: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}